Making End of Life Decision in Ovarian Cancer: When to Enter Hospice? A Prototype Interactive Computer Program for Patients and Providers
In this study, we will pilot-test a technology-based approach for women with Stage III/IV or
recurrent ovarian cancer, their caregiver, and their providers to assist in and study the
decision-making process that surrounds end-of-life decisions, specifically, opting for
palliative care and/or entry into hospice care. We will randomize the women and their
caregivers into either our intervention or control websites. All subjects will complete a
battery of demographic, psychosocial, health status and outcomes, health information, and
decision making measures at baseline and 60-day post-baseline.
Once the participant has completed the baseline survey, he/she will be automatically brought
to their assigned website. Both the patient and their caregiver will be assigned the same
group (intervention or control). All participants will have open access to their respective
study websites for a minimum of 60 days. During enrollment, participants will agree to
access their respective websites at least 2-3 times per week. Both patients and caregivers
assigned to the control arm will view a website containing documents generally provided as
part of the usual care. They will be requested to log in with the same frequency as the
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Comparison of Number of Women Who Completed Advanced Directive
Count of number of women with ovarian cancer who completed a new or updated their Advanced Directive during the study period.
Day 60 After Baseline
Melissa A. Geller, M.D.
Masonic Cancer Center, University of Minnesota
United States: Institutional Review Board
|Masonic Cancer Center, University of Minnesota||Minneapolis, Minnesota 55455|